New Director Supports NASDAQ Rule on Diversity
NEW AIkido Pharma Inc. announced the appointment of Ms. Soo Yu, as a director of the Company.
Anthony Hayes, CEO of AIkido stated, "At the time of the annual meeting, there was concern expressed by some shareholders about the Company's compliance with the new NASDAQ rules on diversity. The Company strongly believes in diversity and Ms. Yu is an exceptional candidate that also satisfies the new NASDAQ rule. Further, Ms. Yu's background broadens the experience and expertise of the Company, as we seek new areas of growth and opportunity for the Company. We welcome Ms. Yu and look forward to her involvement."
Source: AIkido Pharma
Latest Articles
AIkido Pharma,Ms. Soo Yu, Director
NEW AIkido Pharma Inc. announced the appointment of Ms. Soo Yu, as a director of the Company.
